
    
      A maximum of 16 visits will be performed during the clinical trial. During the treatment
      period, visits are scheduled every 4 - 12 weeks. Study procedures include spirometry
      (breathing tests), clinical laboratory tests, a Quality of Life assessment, vital signs,
      physical examinations, and assessment of adverse events.
    
  